We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.78B
AUM Growth
-$68.3M
Cap. Flow
-$132M
Cap. Flow %
-7.44%
Top 10 Hldgs %
16.28%
Holding
390
New
41
Increased
102
Reduced
174
Closed
34

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.23M
2
ASRT
Assertio
ASRT
+$8.76M
3
ITMN
INTERMUNE INC
ITMN
+$8.58M
4
EPZM
Epizyme, Inc
EPZM
+$8.51M
5
KFRC icon
Kforce
KFRC
+$8.18M

Top Sells

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$40.2M
2
AKRX
Akorn Inc
AKRX
+$21.7M
3
BCOV
Brightcove, Inc.
BCOV
+$10.6M
4
REXX
Rex Energy Corporation
REXX
+$8.91M
5
MTH icon
Meritage Homes
MTH
+$8.41M

Sector Composition

Rank Sector Weight
1 Industrials 17.87%
2 Technology 15.37%
3 Healthcare 14.23%
4 Financials 11.54%
5 Consumer Discretionary 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYNO
76
DELISTED
Cynosure, Inc. Class A
CYNO
$7.89M 0.44%
269,322
-8,846
-3% -$251K
PRIM icon
77
Primoris Services
PRIM
$4.66B
$7.84M 0.44%
261,434
+154,654
+145% +$4.89M
KWR icon
78
Quaker Houghton
KWR
$2.62B
$7.83M 0.44%
99,392
– –
IPHI
79
DELISTED
INPHI CORPORATION
IPHI
$7.79M 0.44%
483,902
+20,490
+4% +$277K
CCNE icon
80
CNB Financial Corp
CCNE
$1.02B
$7.65M 0.43%
432,677
+114,006
+36% +$2.03M
IONS icon
81
Ionis Pharmaceuticals
IONS
$8.99B
$7.62M 0.43%
176,436
-145,897
-45% -$7.07M
PTLA
82
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$7.54M 0.42%
291,201
+31,446
+12% +$839K
CCK icon
83
Crown Holdings
CCK
$13.1B
$7.42M 0.42%
165,951
+37,610
+29% +$1.63M
APOG icon
84
Apogee Enterprises
APOG
$856M
$7.42M 0.42%
223,132
+41,302
+23% +$1.41M
ARUN
85
DELISTED
ARUBA NETWORKS, INC.
ARUN
$7.32M 0.41%
390,605
-18,098
-4% -$362K
ENS icon
86
EnerSys
ENS
$7.17B
$7.32M 0.41%
105,568
+57,635
+120% +$4.04M
RALY
87
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$7.28M 0.41%
543,717
-32,233
-6% -$641K
FIVE icon
88
Five Below
FIVE
$11.2B
$7.22M 0.41%
170,065
-135,144
-44% -$5.19M
NSTG
89
DELISTED
NanoString Technologies, Inc.
NSTG
$7.18M 0.4%
347,822
-14,340
-4% -$273K
PRLB icon
90
Protolabs
PRLB
$1.85B
$7.07M 0.4%
104,445
+44,225
+73% +$3.29M
SN
91
DELISTED
Sanchez Energy Corporation
SN
$7M 0.39%
236,291
+133,671
+130% +$3.72M
WTRG icon
92
Essential Utilities
WTRG
$11.3B
$6.9M 0.39%
275,076
+160
+0.1% +$3.86K
DORM icon
93
Dorman Products
DORM
$4.24B
$6.88M 0.39%
116,546
– –
AAOI icon
94
Applied Optoelectronics
AAOI
$8.22B
$6.8M 0.38%
275,588
-21,818
-7% -$406K
CLAR icon
95
Clarus
CLAR
$132M
$6.78M 0.38%
556,665
-6,409
-1% -$74.9K
BMTC
96
DELISTED
Bryn Mawr Bank Corp
BMTC
$6.75M 0.38%
235,065
– –
SRPT icon
97
Sarepta Therapeutics
SRPT
$1.82B
$6.62M 0.37%
275,639
-173,298
-39% -$4.42M
GLPI icon
98
Gaming and Leisure Properties
GLPI
$12.8B
$6.62M 0.37%
181,497
+32,925
+22% +$1.25M
GWRE icon
99
Guidewire Software
GWRE
$12.5B
$6.43M 0.36%
131,101
-9,200
-7% -$461K
EPZM
100
DELISTED
Epizyme, Inc
EPZM
$6.39M 0.36%
+280,752
New +$8.51M
2 3
4
5 6

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2014 Portfolio in Review

As of Q1 2014, Emerald Advisers held 390 positions worth $1.78B, down 3.7% from $1.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Emerald Advisers withdrew a net $132M in Q1 2014, closing 34 positions and reducing 174 holdings. Its most notable exit was Akorn Inc, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Emerald Advisers opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $12.4M.

  • Emerald Advisers's largest Q1 2014 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 817,410 shares worth $12.4M.
  • Emerald Advisers added most to PacWest Bancorp in Q1 2014, an estimated $7.25M increase.
  • Emerald Advisers's biggest Q1 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $40.2M.
  • Emerald Advisers fully exited Akorn Inc in Q1 2014, selling an estimated $21.7M.
  • Emerald Advisers's ten largest holdings make up 16% of its $1.78B portfolio in Q1 2014.
  • Emerald Advisers opened 41 new positions and closed 34 in Q1 2014.
  • Emerald Advisers's portfolio value fell 3.7% quarter-over-quarter to $1.78B.

Based on Emerald Advisers's 13F filing for Q1 2014, filed 30 Apr 2014.